Summit Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US86627T1088
USD
17.94
2.4 (15.44%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summarySummit Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
15.44%
-0.37%
1W
15%
-2.38%
1M
14.41%
-4.84%
YTD
2.57%
-4.22%
1Y
-11.36%
13.68%
3Y
919.32%
65.11%
5Y
226.78%
68.58%
10Y
167.76%
222.03%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.39%
0%
-2.39%
6 Months
-11.45%
0%
-11.45%
1 Year
-11.36%
0%
-11.36%
2 Years
446.95%
0%
446.95%
3 Years
919.32%
0%
919.32%
4 Years
531.69%
0%
531.69%
5 Years
226.78%
0%
226.78%

Summit Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary